Overcoming cancer therapeutic bottleneck by drug repurposing
Ever present hurdles for the discovery of new drugs for cancer therapy have necessitated
the development of the alternative strategy of drug repurposing, the development of old …
the development of the alternative strategy of drug repurposing, the development of old …
Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial
DA Drew, MM Schuck, MV Magicheva-Gupta… - Cancer Prevention …, 2020 - AACR
Low-dose aspirin is recommended by the US Preventive Services Task Force for primary
prevention of colorectal cancer in certain individuals. However, broader implementation will …
prevention of colorectal cancer in certain individuals. However, broader implementation will …
Urinary pge-m in men with prostate cancer
Simple Summary Elevated levels of urinary prostaglandin E metabolite (PGE-M), a marker of
inflammation, have previously been associated with cancer incidence and metastasis …
inflammation, have previously been associated with cancer incidence and metastasis …
Association of urinary prostaglandin E2 metabolite and mortality among adults
Prostaglandins play a critical role in inflammatory response. To investigate the association of
urinary PGE-M, a stable end-product of prostaglandin E2 (PGE2) with overall and cause …
urinary PGE-M, a stable end-product of prostaglandin E2 (PGE2) with overall and cause …
[PDF][PDF] Urinary PGE-M in Men with Prostate Cancer. Cancers 2021, 13, 0
Urinary PGE-M is a stable metabolite of prostaglandin E2 (PGE2). PGE2 is a product of the
inflammatory COX signaling pathway and has been associated with cancer incidence and …
inflammatory COX signaling pathway and has been associated with cancer incidence and …